CEYY Announces Name and Symbol Change MJNA Interview Impresses

Recommended Stock Newsletters
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder

SmallCapVoice Newsletter

CEYY Announces Name and Symbol Change MJNA Interview Impresses —————————————————————– Hot Stock to Watch —————————————————————– Company: Medical Marijuana Inc. (Pink Sheets: MJNA) End of Day:

Price: 0.3175 Change (%): – 0.0105 (3.20) Volume: 9,782,770 http://bit.ly/GFHXYR A New Audio Interview With CannaVest Corp. VP of Product Development, Christopher Boucher and HempMedsPX’s VP of Communications, Charles Vest, is Now at SmallCapVoice.com AUSTIN, Texas, Feb. 19, 2014 (GLOBE NEWSWIRE) – SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with HempMedsPX(TM) – a corporate portfolio company of Medical Marijuana, Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp (OTCBB:CANV) and Medical Marijuana Inc (OTC Pink:MJNA), is now available. The interview can be heard at http://smallcapvoice.com/blog/2-14-14-smallcapvoice-interview-with-medical-marijuana-inc-mjna Continue Reading – http://bit.ly/1eaFO23 —————————————————————– Yesterday`s Top Performer —————————————————————– Company: InferX Corp. (Pink Sheets: NFRX) End of Day:

Price: 0.03 Change (%): + 0.005 (20.00) Volume: 10,000 http://bit.ly/RlzRtg About InferX Corporation InferX is a market leader in next generation distributed Predictive Analytics and Business Intelligence Products and Solutions. InferX has pioneered and commercialized a powerful, patented suite of advanced data analytical solutions that improve corporate performance across the enterprise in the healthcare, financial services, and government markets. The Company has two patents issued for its real time, distributed predictive analytics and business intelligence system. InferX is uniquely capable of delivering secure, real-time, and privacy preserving intelligence and decision support – all without the need to move data. InferX is headquartered in Tysons Corner, VA.

Company Information Sheet – http://www.smallcapvoice.com/nfrx/info.html —————————————————————– SmallCapVoice Clients` News —————————————————————– Company: BioCorRx Inc. (OTCQB: BICX) http://bit.ly/1gilj61 BioCorRx Inc.’s Name Change and New Trading Symbol Approved by FINRA LOS ANGELES, CA-(Marketwired – Feb 19, 2014) – BioCorRx Inc.

(‘the Company’) (OTCQB: BICX) is pleased to announce that Financial Industry Regulatory Authority (“FINRA”) has approved the Company’s application for a name change from Fresh Start Private Management Inc. to BioCorRx Inc. and assigned a new trading symbol, BICX under a new CUSIP number 09073C106. The market effective date for these changes is February 20, 2014.

Until then, the ticker remains (OTCQB: CEYY).

Kent Emry, CEO of Fresh Start Private, stated, “Now we can move forward under a new name that we feel better represents what this company does now, and will do in the future. For now, we are ‘BioCorRx, Developer of the Start Fresh Program.’ In the future, we plan to add other healthcare related products and services under the BioCorRx name, but addiction treatment remains our primary mission.” Continue Reading – http://bit.ly/NbMJSJ —————————————————————– Other Small Cap News —————————————————————– Company: Plandaí Biotechnology, Inc. (OTCQB: PLPL) http://bit.ly/yYIzO5 Plandai Biotechnology Names Diego Pellicer Co-Founder and Cannabis Pioneer Jamen Shively as Vice President of Global Marketing Recently Appointed Board Member Joins Management Team to Oversee Branding and Product Strategy NEW YORK, NY–(Marketwired – Feb 20, 2014) – Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that Jamen Shively, a leading voice in the burgeoning marijuana industry and recently appointed Board Member of Plandaí, has been named as Vice President of Global Marketing.

As VP-Global Marketing, the company released, Mr. Shively will be responsible for building brand awareness and marketing strategy for all of Plandaí`s operations including the Diego Pellicer® medical cannabis line as well as the Phytofare™ botanical extracts such as the Green Tea Catechin Complex and the Limonoid Glycoside Complex.

Continue Reading – http://mwne.ws/1jSJOfQ —————————————————————– Company: True Drinks, Inc. (OTCQB: TRUU) http://bit.ly/14CfQBv True Drinks Announces International Expansion AquaBall Bounces Into Australia and New Zealand IRVINE, CA–(Marketwired – February 20, 2014) – True Drinks, Inc.

(OTCQB: TRUU), a healthy beverage provider with major entertainment and media company licensing agreements for use of their characters on its proprietary, patented bottles, today announced that the Company has secured distribution for AquaBall™ Naturally Flavored Water in Australia and New Zealand through Ezi Group Pty of New South Wales, Australia.

“Since inception, we have had plans of making AquaBall Naturally Flavored Water an international brand. Partnerships like the one we have with Ezi Group allow us the ability to share our brand with children and parents around the world. We continue to grow our distribution through an experienced network of world class distributors, and these relationships will be the cornerstone of our international growth,” said Lance Leonard, CEO of True Drinks.

Continue Reading – http://mwne.ws/1ctS69i —————————————————————– Market News —————————————————————– By Ben Levisohn: Barrons Actavis: Caterpillar Becoming Butterfly; Time to Buy, Goldman Sachs Says Yesterday, Actavis (ACT) wowed investors with its purchase of Forest Labs (FRX). Today, Actavis is heading higher again, as a Goldman Sachs upgrade highlights the transformative impact of the pending acquisition.

Goldman Sachs analyst Jami Rubin and team explain why they upgraded Actavis to Buy from Neutral:

Blurring the distinction between specialty/generics and large cap pharma, we see [Actavis] transforming from a specialty/generic business to a full-fledged pharma company with an equal balance of brands and generics…

Continue Reading – http://on.barrons.com/1jg9W1c —————————————————————– By Kristen Wyatt: AP Governor: Colorado pot market exceeds tax hopes DENVER (AP) – Colorado`s legal marijuana market is far exceeding tax expectations, according to a budget proposal released Wednesday by Gov. John Hickenlooper that gives the first official estimate of how much the state expects to make from pot taxes.

The proposal outlines plans to spend some 99 million dollars next fiscal year on substance abuse prevention, youth marijuana use prevention and other priorities. The money would come from a statewide 12.9 percent sales tax on recreational pot. Colorado`s total pot sales next fiscal year were estimated to be about 610 million dollars.

Retail sales began Jan. 1 in Colorado. Sales have been strong, though exact figures for January sales won`t be made public until early next month.

The governor predicted sales and excise taxes next fiscal year would produce some $98 million, well above a 70 million dollars annual estimate given to voters when they approved the pot taxes last year. The governor also includes taxes from medical pot, which are subject only to the statewide 2.9 percent sales tax.

Continue Reading – http://yhoo.it/1gl71So —————————————————————– IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY —————————————————————– SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security.

SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com.

opt out of our distribution list at any time by clicking on the “

This entry was posted in SmallCapVoice and tagged , , , , , , . Bookmark the permalink.

Comments are closed.